Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
Annals of Surgery|September 18, 2025
The Rise of Robot-Assisted Surgery in the Netherlands: An Overview of its Adoption over the Last DecadeMaurits R Visser, Femke J Amelung, J P Maarten Burbach, et al.
Annals of Surgery|August 2, 2021
Survival Benefit Associated With Resection of Locally Advanced Pancreatic Cancer After Upfront FOLFIRINOX Versus FOLFIRINOX Only: Multicenter Propensity Score-matched AnalysisLilly J H Brada, Lois A Daamen, Lisa G Magermans, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|June 26, 2019
Implementation and outcome of minor and major minimally invasive liver surgery in the NetherlandsMarcel J van der Poel, Robert S Fichtinger, Marc Bemelmans, et al.
The British Journal of Surgery|July 1, 2021
Comparing practice and outcome of laparoscopic liver resection between high-volume expert centres and nationwide low-to-medium volume centresB Görgec, R S Fichtinger, F Ratti, et al.
BMC Medicine|March 3, 2022
Risk factors associated with short-term adverse events after SARS-CoV-2 vaccination in patients with immune-mediated inflammatory diseasesLuuk Wieske, Laura Y L Kummer, Koos P J van Dam, et al.
Journal of Autoimmunity|January 9, 2023
Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinationsKoos P J van Dam, Luuk Wieske, Eileen W Stalman, et al.
BMC Infectious Diseases|May 17, 2023
Primary SARS-CoV-2 infection in patients with immune-mediated inflammatory diseases: long-term humoral immune responses and effects on disease activityKoos P J van Dam, Adriaan G Volkers, Luuk Wieske, et al.
The Journal of Dermatology|February 14, 2025
Impact of COVID-19 disease and vaccination on dermatological immune-mediated inflammatory diseases atopic dermatitis, psoriasis, and vitiligo: a Target2B! substudyNicoline F van Buchem-Post, Wouter Ouwerkerk, Eileen W Stalman, et al.
Annals of the Rheumatic Diseases|November 10, 2022
Breakthrough infections with the SARS-CoV-2 omicron (B.1.1.529) variant in patients with immune-mediated inflammatory diseasesEileen W Stalman, Luuk Wieske, Koos P J van Dam, et al.
The Lancet. Rheumatology|March 23, 2022
Humoral responses after second and third SARS-CoV-2 vaccination in patients with immune-mediated inflammatory disorders on immunosuppressants: a cohort studyLuuk Wieske, Koos P J van Dam, Maurice Steenhuis, et al.
Pageof 9